ICS OPPORTUNITIES LTD. 13D and 13G filings for Albireo Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-02 4:26 pm Purchase |
2023-02-21 | 13G | Albireo Pharma, Inc. ALBO |
ICS OPPORTUNITIES LTD. | 999,363 4.800% |
999,363 (New Position) |
Filing |